{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:18:18Z","timestamp":1788135498031,"version":"build-2803163510"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Amyotrophic lateral sclerosis (ALS) is a rare, progressive neurodegenerative disorder, with a substantial proportion of cases attributed to genetic factors. Recent advances in gene discovery and genomic technologies have transformed ALS care by enabling genomic testing to inform prognosis, assess familial risk, and facilitate access to novel therapies. However, guidance on the delivery of genetic testing and counselling in ALS remains limited, leading to variability in clinical practice. In response, the Manchester Motor Neuron Disease (MND) Care Centre and the Manchester Centre for Genomic Medicine co-developed a structured genetic care pathway for ALS, drawing on real-world data, patient engagement, and multidisciplinary collaboration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A retrospective evaluation of 326 ALS patients at the Manchester MND Care Centre identified significant variability in genetic testing uptake, counselling practices, and record-keeping. Patient survey and engagement sessions revealed uncertainty regarding key genetic concepts and inconsistent recall of pre- and post-test discussions. Priorities for improvement included clearer communication, standardised discussions, and enhanced support for families following genetic findings. Consequently, the Greater Manchester ALS Genetic Testing Pathway was developed by a multidisciplinary team, incorporating consensus-based steps for patient identification, pre-test conversations, consent, testing, results disclosure, and post-test support. This pathway integrates genetic testing into routine ALS care, clarifies team responsibilities, and establishes a framework for ongoing evaluation using key performance indicators. Patient and staff feedback is used to support continuous improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The co-developed ALS genetic testing pathway provides a scalable model for standardising genomic care in mainstream clinical settings. By establishing clear processes for genetics discussions, consent, and follow-up, the pathway seeks to improve equity, transparency, and person-centred care. Ongoing evaluation and collaboration with patients, clinicians, and genetic services are essential to ensure the pathway remains responsive to scientific advances and evolving patient needs. Wider adoption of structured genetic pathways may facilitate the integration of genomics into care for rare diseases across healthcare systems.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04417-z","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:14:01Z","timestamp":1781673241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Co-development of a genetic care pathway for ALS: real-world perspectives from the North of England"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0332-1793","authenticated-orcid":false,"given":"Clementine","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Chalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha Holden","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Broadhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ealing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Hamdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Breen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhona","family":"Macleod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Chaouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"2","key":"4417_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/nejmra1603471","volume":"377","author":"RH Brown","year":"2017","unstructured":"1, Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162\u201372. https:\/\/doi.org\/10.1056\/nejmra1603471.","journal-title":"N Engl J Med"},{"key":"4417_CR2","doi-asserted-by":"crossref","unstructured":"Chaouch A, Crook A, Andrew, McDermott CJ, Ammar Al-Chalabi, McNeill A, et al. The use of genetic testing in amyotrophic lateral sclerosis (ALS): a practical approach. Amyotroph Lateral Scler Frontotemporal Degeneration. 2025;1\u20137.","DOI":"10.1080\/21678421.2025.2539895"},{"key":"4417_CR3","doi-asserted-by":"crossref","unstructured":"Ak\u00e7imen F, et al. Amyotrophic lateral sclerosis: translating genetic discoveries into therapies. Nat reviews Genet vol. 2023;24:642\u201358. https:\/\/doi.org\/10.1038\/s41576-023-00592-y.","DOI":"10.1038\/s41576-023-00592-y"},{"issue":"5\u20136","key":"4417_CR4","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1080\/21678421.2025.2465609","volume":"26","author":"J Alder","year":"2025","unstructured":"Alder J, Chukwuma C, Farragher T, Holden Smith S, Morris R, Ealing J, et al. Impact of relative deprivation and ethnicity on the incidence rate of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degeneration. 2025;26(5\u20136):558\u201365.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degeneration"},{"key":"4417_CR5","unstructured":"NHS England. National Genomic Test Directory [Internet]. England.nhs.uk. 2018. Available from: https:\/\/www.england.nhs.uk\/publication\/national-genomic-test-directories\/"},{"key":"4417_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/21678421.2022.2150556","volume":"24","author":"M De Oliveira, Hugo","year":"2023","unstructured":"De Oliveira, Hugo M, et al. A survey of current practice in genetic testing in amyotrophic lateral sclerosis in the UK and Republic of Ireland: implications for future planning. Amyotroph lateral Scler frontotemporal degeneration vol. 2023;24:5\u20136. https:\/\/doi.org\/10.1080\/21678421.2022.2150556.","journal-title":"Amyotroph lateral Scler frontotemporal degeneration vol"},{"key":"4417_CR7","unstructured":"Optimal clinical pathway for adults: Neurogenetics National Neurosciences Advisory Group (NNAG) [Internet]. 2023 [cited 2026 Jan 5]. Available from:"},{"issue":"1","key":"4417_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s13023-020-01631-1","volume":"15","author":"R Talarico","year":"2020","unstructured":"Talarico R, Cannizzo S, Lorenzoni V, et al. RarERN Path: a methodology towards the optimisation of patients\u2019 care pathways in rare and complex diseases developed within the European Reference Networks. Orphanet J Rare Dis. 2020;15(1):347. https:\/\/doi.org\/10.1186\/s13023-020-01631-1. Published 2020 Dec 14.","journal-title":"Orphanet J Rare Dis"},{"key":"4417_CR9","unstructured":"Record of Discussion Regarding Genomic Testing [Internet]. Available from: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2021\/09\/nhs-genomic-medicine-service-record-of-discussion-form.pdf"},{"key":"4417_CR10","unstructured":"Developing a patient decision aid to support genetic testing in MND [Internet]. MND Association. 2022 [cited 2025 Dec 26]. Available from: https:\/\/www.mndassociation.org\/research\/our-research\/research-we-fund\/improving-standards-of-care\/decision-aid-for-genetic-testing"},{"issue":"7","key":"4417_CR11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/jmg-2023-109735","volume":"61","author":"J Howard","year":"2024","unstructured":"Howard J, Bekker HL, McDermott CJ, McNeill A. Survey of service needs to embed genome sequencing for motor neuron disease in neurology in the English National Health Service. J Med Genet. 2024;61(7):661\u20135. https:\/\/doi.org\/10.1136\/jmg-2023-109735. Published 2024 Jun 20.","journal-title":"J Med Genet"},{"issue":"4","key":"4417_CR12","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.ajhg.2019.02.025","volume":"104","author":"Y Bombard","year":"2019","unstructured":"Bombard Y, Brothers KB, Fitzgerald-Butt S, et al. The Responsibility to Recontact Research Participants after Reinterpretation of Genetic and Genomic Research Results. Am J Hum Genet. 2019;104(4):578\u201395. https:\/\/doi.org\/10.1016\/j.ajhg.2019.02.025.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"4417_CR13","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s13023-021-02092-w","volume":"16","author":"D Choukair","year":"2021","unstructured":"Choukair D, Hauck F, Bettendorf M, et al. An Integrated clinical pathway for diagnosis, treatment and care of rare diseases: model, operating procedures, and results of the project TRANSLATE-NAMSE funded by the German Federal Joint Committee. Orphanet J Rare Dis. 2021;16(1):474. https:\/\/doi.org\/10.1186\/s13023-021-02092-w. Published 2021 Nov 12.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"4417_CR14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/archneurol.2010.351","volume":"68","author":"H Daoud","year":"2011","unstructured":"Daoud H, Valdmanis PN, Gros-Louis F, et al. Resequencing of 29 candidate genes in patients with familial and sporadic amyotrophic lateral sclerosis. Arch Neurol. 2011;68(5):587\u201393. https:\/\/doi.org\/10.1001\/archneurol.2010.351.","journal-title":"Arch Neurol"},{"issue":"3","key":"4417_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1399-0004.2012.01900.x","volume":"83","author":"R MacLeod","year":"2013","unstructured":"MacLeod R, Tibben A, Frontali M, Evers-Kiebooms G, Jones A, Martinez-Descales A, et al. Recommendations for the predictive genetic test in Huntington\u2019s disease. Clin Genet [Internet]. 2013;83(3):221\u201331.","journal-title":"Clin Genet [Internet]"},{"key":"4417_CR16","doi-asserted-by":"crossref","unstructured":"McNeill A, Amador MM, Bekker H, Clarke A, Crook A, Cummings C et al. Predictive genetic testing for Motor neuron disease: time for a guideline? European Journal of Human Genetics [Internet]. 2022;30(6):635\u20136. Available from: https:\/\/www.nature.com\/articles\/s41431-022-01093-y","DOI":"10.1038\/s41431-022-01093-y"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04417-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04417-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04417-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:04:39Z","timestamp":1788134679000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04417-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4417"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04417-z","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval for the study was obtained from the Research and Innovation Department of the Northern Care Alliance NHS group (Ref: 25HIP42). Data were accessed for this project between 1\/01\/2025 and 31\/12\/2025.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The service evaluation was an observational retrospective anonymised study. The review board determined that consent was not required.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"304"}}